In a mouse model of NAFLD, the TP53 inhibitor pifithrin-p-nitro (PFT) caused attenuating steatosis, oxidative stress, and apoptosis [95]. This evidence concerns the gene TP53 and metabolic dysfunction-associated steatotic liver disease.